在线看片免费不卡人成视频_中文av中文在线_亚洲精品素人在线观看_欧美华人在线视频
Home
About
About Us
Team
Contact
News
Science
Our Science
Clinical trials
Expanded access policy
Pipeline
Career
Work in highlightll pharma
Join Us
中文
中文
|
中文
Home
About
News
Science
About
About Us
Team
Contact
Hangzhou Highlightll News
We strive to discover breakthrough medicines which would have high impact on health care
The current position:
Home
/
News
/
Company news
Return
Vial Announces Enrollment of First Patient in Phase II Clinical Trial TLL018- 205 for the Treatment of Plaque Psoriasis Sponsored by Highlightll Pharmaceutical
January 19,2023 From:
https://finance.yahoo.com/news/vial-announces-enrollment-first-patient-220000750.html
Prev
Highlightll Pharmaceutical TLL-018 Achieved Breakthrough Results in a Phase II Trial for Rheumatoid Arthritis
Next
HANGZHOU HIGHLIGHTLL: TWICE THE TARGET, HOLD THE TOX
Return List
About
About Us
Team
Contact
News
Company news
Career
Work in highlightll pharma
Join Us
Contact
Add
RM 301/302, BLDG 4, Qiantang District, Hangzhou 310018, China
Tel
+86-0571-88881586
Email
info@highlightpharma.com
Copyright ? 2021-2022 HIGHLIGHTLL PHARMA All Rights Reserved
浙ICP備2021020990號-1
Power By:
Baling